Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis-Reference-Cited by-同舟云学术

Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis

Published:2016-05-13 Issue:5 Volume:2016 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Singh Jasvinder A¹,Hossain Alomgir²,Tanjong Ghogomu Elizabeth³,Kotb Ahmed²,Christensen Robin⁴,Mudano Amy S⁵,Maxwell Lara J⁶,Shah Nipam P⁷,Tugwell Peter⁸,Wells George A⁹

Affiliation:

1. Birmingham VA Medical Center; Department of Medicine; Faculty Office Tower 805B 510 20th Street South Birmingham AL USA 35294

2. University of Ottawa Heart Institute; Cardiovascular Research Methods Centre; 40 Ruskin Street Room H-2265 Ottawa ON Canada K1Y 4W7

3. University of Ottawa; Bruyère Research Institute; 43 Bruyère St Annex E, room 302 Ottawa ON Canada K1N 5C8

4. Copenhagen University Hospital, Bispebjerg og Frederiksberg; Musculoskeletal Statistics Unit, The Parker Institute; Nordre Fasanvej 57 Copenhagen Denmark DK-2000

5. University of Alabama at Birmingham; Department of Medicine - Rheumatology; Birmingham USA

6. Ottawa Hospital Research Institute (OHRI), The Ottawa Hospital - General Campus; Centre for Practice-Changing Research (CPCR); 501 Smyth Road, Box 711 Ottawa ON Canada K1H 8L6

7. University of Alabama at Birmingham; Department of Clinical Immunology and Rheumatology; Faculty Office Tower, Suite 805, 510 20th Street South Birmingham AL USA 35294

8. Faculty of Medicine, University of Ottawa; Department of Medicine; Ottawa ON Canada K1H 8M5

9. University of Ottawa; Department of Epidemiology and Community Medicine; Room H1281 40 Ruskin Street Ottawa ON Canada K1Y 4W7

Publisher

Wiley

Subject

Pharmacology (medical)

Reference287 articles.

1. A multicenter, double-blind, randomized, placebo controlled trial of infliximab combined with low dose methotrexate in Japanese patients with rheumatoid arthritis;Abe;The Journal of Rheumatology,2006

2. Improved health outcomes with etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis;Bae;BMC Musculoskeletal Disorders,2013

3. Randomized, double-blind, placebo-controlled, comparative study of human anti-TNF antibody adalimumab in combination with methotrexate and methotrexate alone in Taiwanese patients with active rheumatoid arthritis;Chen;Journal of the Formosan Medical Association,2009

4. Certolizumab pegol plus MTX administered every 4 weeks is effective in patients with RA who are partial responders to MTX;Choy;Rheumatology,2012

5. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial;Cohen;Arthritis and Rheumatology,2002

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cellular spermine targets JAK signaling to restrain cytokine-mediated autoimmunity;Immunity;2024-08

2. Twenty years of network meta‐analysis: Continuing controversies and recent developments;Research Synthesis Methods;2024-01-18

3. Initial Treatment with Biological Therapy in Rheumatoid Arthritis;Journal of Clinical Medicine;2023-12-21

4. How do network meta-analyses address intransitivity when assessing certainty of evidence: a systematic survey;BMJ Open;2023-11

5. Cost–utility analysis of tapering strategies of biologicals in rheumatoid arthritis patients in the Netherlands;Annals of the Rheumatic Diseases;2023-07-09